Dirk Collevecchio
Adult Health · San Francisco, CANPI 1467931360
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 337 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $4,248 and has fallen 98.8% since, to $50 in 2023. Among adult health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 337 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Viiv Healthcare Company$1K
- Gilead$876
- EMD Serono, Inc.$335
- Johnson & Johnson$330
- Novo Nordisk$323
- plus $3K from 30 others
What the payments were for
- Speaking & faculty fees$170%
- Food & beverage$6,54296%
- Education$2283%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $1,093 |
| Viiv Healthcare Company | 45 | $1,023 |
| Gilead | 47 | $876 |
| EMD Serono, Inc. | 19 | $335 |
| Johnson & Johnson(2 entities) | 22 | $330 |
| Novo Nordisk | 19 | $323 |
| Merck | 14 | $280 |
| AstraZeneca | 14 | $270 |
| Bausch Health US, LLC | 12 | $215 |
| Janssen Products, LP | 2 | $200 |
| Theratechnologies Inc. | 7 | $175 |
| Amarin Pharma, Inc. | 9 | $167 |
| Biohaven Pharmaceuticals, Inc. | 6 | $137 |
| Boehringer Ingelheim | 8 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $123 |
| Eisai Inc. | 6 | $119 |
| Bayer | 5 | $110 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $107 |
| Lilly USA, LLC | 5 | $101 |
| Nestle Healthcare Nutrition Inc. | 3 | $66 |
| Antares Pharma, Inc. | 2 | $66 |
| Teva Pharmaceuticals USA, Inc. | 2 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| Adlon Therapeutics L.p. | 3 | $57 |
| GSK | 2 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $48 |
| Amgen | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Acerus Pharmaceuticals Corporation | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Apria Healthcare LLC | 1 | $22 |
| Clarus Therapeutics Inc. | 1 | $20 |
| Medtronic | 1 | $17 |
| Napo Pharmaceuticals Inc | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Janssen Scientific Affairs, LLC | 1 | $11 |
How this compares
$6,788 in reported general payments places this provider in the 95th percentile of 785 adult health providers in California.
Other adult health in San Francisco
- Stephany RodriguezSan Francisco$27K
- Emily PepeSan Francisco$12K
- Sarah DonahueSan Francisco$9K
- Karolina FaysmanLos Angeles$1.1M
- Linda BuckLos Angeles$170K
- Naomi PesynaAnaheim$141K
- Stacy GrissenEncinitas$82K
- Kimberly PodsadaSan Diego$78K
- Brenda PatrickSan Leandro$68K
- Brittany PolizziEncinitas$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.